Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox 4 like 8 (DUX4L8) is a human gene annotated as a pseudogene and described by the HUGO Gene Nomenclature Committee (HGNC). It does not encode a functional protein and has no documented disease association, biological function, or interaction with therapeutics. Its status and locus type are formally "pseudogene," meaning it is a non-functional genomic DNA sequence related to a gene with a biological role, most closely resembling the DUX4 gene which encodes a double homeobox protein involved in transcription regulation and disease[1][3][5]. DUX4L8 should not be confused with DUX4, which is a validated therapeutic and research target[2][4]. Note: If you are seeking information about the double homeobox protein implicated in therapy or disease, the proper target is Double homeobox 4 (DUX4), not DUX4L8. DUX4 is a transcription factor involved in muscular dystrophy and leukemia[2][4]. DUX4L8 is just a pseudogene and does not encode a protein, therefore not suitable for therapeutic targeting, biomarker analysis, or pharmacological modulation[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox 4 like 8 (DUX4L8).